Floatz logo

18F-ASIS

Prostate Cancer

Memorial Sloan Kettering Cancer CenterPhase 2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
59/ 100

Competitive context

426 Active assets in the Prostate Cancer cohort.

Asset / SponsorPhaseRating
Degarelix
Bayer
Phase 4BBB
Flotufolastat F-18
Washington University School of Medicine
Phase 4BB
AVOLVE
Masonic Cancer Center, University of Minnesota
Phase 4BB
Estramustine
The University of Texas Health Science Center, Houston
Phase 3BB
PREDNISONE TABLETS
Mayo Clinic
Phase 4BB

View all 50 →

Same molecule, other indications

18F-ASIS is also rated in:

Inflammatory Demyelinating DiseaseDormant
CCC
Indicative ·
53 / 100
View asset →
Thymus NeoplasmsDormant
CCC
Indicative ·
53 / 100
View asset →
Non-small Cell Lung CancerDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →